Thyroid Dysfunctions in Sudanese Patients with Vitiligo

被引:0
|
作者
Osman, A. M. [1 ]
Mirghani, Y. A. [2 ]
机构
[1] Univ Khartoum, Med Biochem, Khartoum, Sudan
[2] Univ Khartoum, Fac Med, Khartoum, Sudan
来源
SUDAN JOURNAL OF MEDICAL SCIENCES | 2010年 / 5卷 / 01期
关键词
T-3; Triiodothyronin; T-4; Tetraiodothyronin; TSH Thyroid stimulating hormone;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Vitiligo is a chronic acquired skin condition that causes loss of pigment, resulting in irregular pale patches of skin. The precise cause of vitiligo is not fully understood. The autoimmune base of the disease is supported by the frequent observation that several autoimmune disorders, particularly thyroid diseases, are associated with vitiligo. Objective: To determine the frequency of thyroid dysfunctions in Sudanese patients with vitiligo. Methods: Two groups, i.e. vitiligo patients and control, were collected with simple random collection. The control group included individuals free of vitiligo. 5 ml of venous blood was taken from every individual in both groups and the ELISA test was done for thyroid hormones, i.e. T-3, T-4 and TSH, using the DRG-USA kits. Results: The number of patients with vitiligo in the study was 46, while the control group was 45. Nine (19.56%) patients were found to have abnormal levels of thyroid hormones. No abnormal levels in the control group. Mean T-3 level in patients was 1.463ng/l, while in control group it was 1.467ng/l. Mean T-4 level in patients was 102.761 nmol/l, while in control group it was 90.844 nmol/l. Mean TSH level in patients was 0.841 mu IU/l, while in control group it was 1.50 mu IU/l. The t-test was done to determine the significance of difference between means of T-3, T-4, and TSH between the patients and control groups. The P-values were found to be significant. Conclusion: There is a strong pathogenetic relationship between vitiligo in Sudanese patients and thyroid dysfunctions.
引用
收藏
页码:28 / 31
页数:4
相关论文
共 50 条
  • [41] Autoimmune thyroid disease in Italian patients with non-segmental vitiligo
    Meena Arunachalam
    Lisa Pisaneschi
    Roberta Colucci
    Federica Dragoni
    Rossana Conti
    Silvia Moretti
    European Journal of Dermatology, 2014, 24 : 625 - 626
  • [42] Characteristics of vitiligo patients with versus without associated autoimmune thyroid disease
    Ma, Ze
    Cao, Peng
    Cai, Menghan
    Lin, Qiuping
    Long, Xiaoyan
    Ge, Man
    Yu, Jipeng
    He, Sijia
    Yu, Jibin
    Zhang, Junling
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, 63 (04) : 491 - 496
  • [43] Thyroid dysfunctions secondary to cancer immunotherapy
    Chalan, P.
    Di Dalmazi, G.
    Pani, F.
    De Remigis, A.
    Corsello, A.
    Caturegli, P.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2018, 41 (06) : 625 - 638
  • [44] AN OLD DILEMMA: SUBCLINICAL THYROID DYSFUNCTIONS
    Vulpoi, Carmen
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (04): : 843 - 850
  • [45] RATIONAL AND EFFICIENT DIAGNOSIS OF THYROID DYSFUNCTIONS
    SCHWARZFISCHER, P
    FORTSCHRITTE DER MEDIZIN, 1977, 95 (13) : 845 - 850
  • [46] Thyroid dysfunctions secondary to cancer immunotherapy
    P. Chalan
    G. Di Dalmazi
    F. Pani
    A. De Remigis
    A. Corsello
    P. Caturegli
    Journal of Endocrinological Investigation, 2018, 41 : 625 - 638
  • [47] Thyroid dysfunctions in morphoea: A preliminary report
    Hassan, Iffat
    Arif, Tasleem
    Anwar, Parvaiz
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2014, 80 (06):
  • [48] Thyroid diseases and female sexual dysfunctions
    Barbagallo, Federica
    Cannarella, Rossella
    Condorelli, Rosita A.
    Cucinella, Laura
    La Vignera, Sandro
    Nappi, Rossella E.
    Calogero, Aldo E.
    SEXUAL MEDICINE REVIEWS, 2024, 12 (03) : 321 - 333
  • [49] Labour market implications of thyroid dysfunctions
    Montagna, Catia
    Zangelidis, Alexandros
    ECONOMICS & HUMAN BIOLOGY, 2023, 50
  • [50] Thyroid dysfunctions secondary to cancer immunotherapy
    Anceau, Christine Cugnet
    Abeillon, Juliette
    Maillet, Denis
    Borson-Chazot, Francoise
    Disse, Emmanuel
    BULLETIN DU CANCER, 2020, 107 (02) : 262 - 271